The Pharmacy Times® Eye Care Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of eye diseases and conditions, including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma.
September 5th 2025
Pavblu, a biosimilar to Eylea, also showed no clinically meaningful differences in efficacy, safety, and immunogenicity in patients with neovascular age-related macular degeneration (nAMD).
FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma
August 16th 2023Melphalan/hepatic delivery system (Hepzato Kit; Delcath Systems Inc) is currently the only liver-directed therapy approved by the FDA for the treatment of netastatic uveal melanoma and percutaneous hepatic perfusion.
Read More